Preclinical firms donate mouse models for rare disease study
Animal model maker Taconic Biosciences has announced it will use CRISPR-Cas9 technology to breed custom mice to study Vici Syndrome.
Animal model maker Taconic Biosciences has announced it will use CRISPR-Cas9 technology to breed custom mice to study Vici Syndrome.
Testing laws introduced after Nazi attrocities in the 40s combined with the paucity of validated in vitro toxicity assays mean animal models are still essential for preclinical research say experts.
Google has announced plans to launch its life sciences team as a standalone unit under its new Alphabet structure.
Drugmakers trying to make blue or green pills for the US market have a new option after the FDA approved a bacteria-derived extract developed by Colorcon for pharma applications.
QuVa Pharma has bought an outsourcing facility from Healix in the first step in an effort to establish a national compounding pharmacy chain.
Pfizer has received the final regulatory clearances to acquire Hospira but the US FTC says it must divests four sterile injectable products.
Hemispherx has signed supply deals with US blood centres to address supply issues that delayed relaunch of genital wart drug, Alferon.